Accenture Treasury Stock increased by 11.1% to $10.97B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.9%, from $12.32B to $10.97B. Over 5 years (FY 2020 to FY 2025), Treasury Stock shows an upward trend with a 25.6% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.64B | $3.41B | $4.08B | $5.30B | $6.12B | $6.68B | $5.17B | $5.59B | $6.13B | $7.06B | $8.03B | $8.79B | $10.00B | $10.56B | $11.30B | $12.32B | $14.00B | $7.75B | $9.88B | $10.97B |
| QoQ Change | — | -26.5% | +19.7% | +29.8% | +15.6% | +9.1% | -22.6% | +8.2% | +9.5% | +15.3% | +13.7% | +9.4% | +13.7% | +5.7% | +7.0% | +9.0% | +13.6% | -44.6% | +27.4% | +11.1% |
| YoY Change | — | — | — | — | +32.0% | +95.9% | +26.7% | +5.6% | +0.1% | +5.8% | +55.4% | +57.2% | +63.2% | +49.6% | +40.7% | +40.2% | +40.0% | -26.6% | -12.6% | -10.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.